Introduction {#s1}
============

Urticaria is a common skin reaction characterized by itchy short-lived elevated erythematous wheals anywhere on the skin. Acute urticaria is associated with symptoms for less than 6 weeks, and is considered to be recurrent acute if the duration of symptom-free periods between urticaria episodes is longer than 6 weeks \[[@B1]\]. Although a specific cause is not frequently identified, the onset of acute urticaria has been associated with allergic reactions to foods and drugs, contact with chemicals, physical stimuli, or infections.

Nearly all of the numerous studies reporting evidence for infectious agents triggering acute or recurrent acute urticaria are retrospective observational studies without appropriate controls or are case reports. Different studies reported a rate ranging from 37% to 58% of multiple infections among 54 or 79 patients with acute urticaria, respectively \[[@B2],[@B3]\]. Another study highlighted the role of *Mycoplasma pneumoniae* infection, which occurred in 32% of 65 children with acute urticaria \[[@B4]\]. Other reports focused on an association between acute urticaria and streptococcal infection, hepatitis A and B viruses, parvovirus B19, cytomegalovirus (CMV), coxsackie A9 virus, enterovirus, influenza A and parainfluenza viruses \[[@B5]-[@B10]\]. Acute urticaria has also been observed after influenza vaccination \[[@B11]\]. Upper respiratory or digestive symptoms are common with acute urticaria associated with infections \[[@B10],[@B12],[@B13]\]. These studies do not provide a compelling case for causal link between a specific infection and the development of urticaria. Reports of herpesvirus infections are frequent but reports of associated urticaria are few. We thus investigated the association of herpes simplex virus (HSV) types 1 and 2, Epstein-Barr virus (EBV), CMV and human herpesvirus-6 (HHV-6) with acute or recurrent acute urticaria.

Methods {#s2}
=======

Ethical statement {#s2.1}
-----------------

The study was approved by the local ethical committee named Comitato Etico del Dipartimento di Medicina Sperimentale e Sanità Pubblica, Università dell'Aquila, L'Aquila, Italy. Written consent was obtained from each subject or their parent or guardian. The local ethical committee approved the written consent process. Consent was documented in writing.

Subjects {#s2.2}
--------

A prospective study was performed from November 1, 2005 to October 30, 2010, and included 37 patients, 26 of whom were outpatients and 11 were hospitalized due to a first attack of acute urticaria. All patients had a physical examination and history that included time of onset of disease, frequency duration size and distribution of wheals, diurnal variation, shape, associated angioedema, family history of urticaria and atopy, previous or current allergies, infections, gastric/intestinal problems, use of drugs, and correlation to food. The diagnosis of urticaria was made by the appearance of circumscribed, slightly elevated, erythematous, edematous papules or wheals. Lesions varied from moment to moment and disappeared within minutes or hours. As controls 37 children who were healthy or had mild acute respiratory infections, who were predominantly siblings or playmates of the patients, were age-matched to within one year of the cases and had the same diagnostic studies. Both cases and controls were followed every 3 to 6 months for 1 to 6 years (mean: 4.2 years and 3.8 respectively).

Laboratory investigations {#s2.3}
-------------------------

Laboratory tests at enrollment for cases included complete blood counts, platelets, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), aspartate transaminase (AST), alanine transaminase (ALT), and urine examination. In all cases serum immunoglobulin (IgG, IgA, IgM, IgE) were examined.

In both cases and controls at enrollment EBV-DNA, CMV-DNA and HHV-6-DNA were detected in the serum and saliva with the use of Real-Time polymerase-chain-reaction. IgG and IgM antibodies against HSV, EBV, CMV, and HHV-6 were examined in serum samples, using commercial enzyme-linked immunosorbent assay from Radim (Pomezia, Italy) and Sorin (Saluggia, Italy). A viral infection was considered as active if high levels of virus-specific IgM antibodies were initially detected with an increase in concentration of viral specific IgG antibodies or HSV-1/2, EBV, CMV or HHV-6 DNA was detected in at least one sample. Other enrollment studies for cases and controls included IgG and IgM anti-adenovirus, respiratory syncythial virus, influenza virus and parvovirus B19 as well as rotavirus detection in the stools. Group A streptococcal infection was diagnosed if a throat swab was positive and/or a significant ASO increase (≥ double of previous one) occurred. Specific IgG and IgM antibodies towards *Mycoplasma* and *Chlamydia pneumoniae* were performed in children with upper respiratory infections. *Helicobacter pylori* and specific IgG antibodies were tested for in children with recurrent abdominal pain.

Allergic studies included skin prick and total and specific IgE. Skin test was determined by using undiluted commercial allergens (cow's milk, whole eggs, chocolate, tomato, grasses, olive, Parietaria, Artemisia, Alternaria, Ambrosia, Betulla, *Dermatophagoides pteronyssinus*, *Dermatophagoides farinae*, Penicillium, dog, cat). A positive histamine control skin test was performed. A positive skin test was defined as inducing a reaction with a wheal size measuring 3 mm or more after subtraction of the control value. Specific IgE antibodies to bovine milk proteins (α-lactalbumin, β-lactoglobulin, and casein) was determined by radioallergosorbent assay (RAST).

Statistical analysis {#s2.4}
--------------------

Statistical analyses were done in part with JMP8.0 (SAS Institute Inc.). McNemar's chi square tests were used for paired comparisons. Variables with a univariate P value of \<0.2 were included in a logistic regression model. Multinomial logistic regression to analyze a 1-1 matched case-control study was performed using IBM SPSS Statistics Version 19 (2010, SPSS Inc).

Results {#s3}
=======

Clinical manifestations of urticaria {#s3.1}
------------------------------------

[Tables 1](#pone-0085378-t001){ref-type="table"} and [2](#pone-0085378-t002){ref-type="table"} describe the characteristics of cases and controls. The mean age of the cases and controls was 3.8 years ([Table 3](#pone-0085378-t003){ref-type="table"}) with a range from 1 month to 15 years. Twenty of 37 (54%) cases had a single episode of acute urticaria, and the remaining 17 (46%) had recurrent acute urticaria. While acute urticaria prevailed in children younger than 2 or older than 6 years of age, recurrent urticaria occurred more frequently in children between 2 and 6 years (p \<0.05). Urticaria was associated with other clinical manifestations in 27 cases (73%).

10.1371/journal.pone.0085378.t001

###### Clinical manifestations and infections in children with acute or acute recurrent urticaria.

  **Cases**     **Gender**     **Age (years)**     **Urticaria**     **Clinical disease concurrent with urticaria**   **Infections concurrent with urticaria**   **Positive diagnostic tests**         **Allergic data**                                           **Hospital days**
  ------------- -------------- ------------------- ----------------- ------------------------------------------------ ------------------------------------------ ------------------------------------- ----------------------------------------------------------- -------------------
  1\.           M              1.1                 Acute             Herpes labialis                                  HSV-1                                      IgM                                   RAST: cow\'s milk 0.55 kU/L                                 none
  2\.           M              1.3                 Acute             Pneumonia                                        none                                       None                                  Atopic dermatitis                                           none
  3\.           M              4                   Acute             Gastroenteritis                                  GAS**^*\**^**                              ASO 1375 IU/ml                        Total IgE 181 kU/L                                          6
                                                                                                                      HHV-6                                      DNA saliva                                                                                        
                                                                                                                      Rotavirus                                  Antigen in stools                                                                                 
  4\.           F              7                   Acute recurrent   Pneumonia                                        *M. pneumoniae*                            IgM                                                                                               8
                                                                                                                      EBV                                        IgM                                                                                               
  5\.           M              7.5                 Acute recurrent   Pharyngotonsillitis                              EBV                                        DNA blood/saliva                      RAST: cow\'s milk 0.36 kU/L                                 none
  6\.           F              11                  Acute             Pneumonia                                        *M. pneumoniae*                            IgM                                                                                               5
  7\.           F              5.4                 Acute recurrent   none                                             CMV                                        DNA urine                                                                                         none
                                                                                                                      ParvovirusB19                              IgM                                                                                               
  8\.           M              6.2                 Acute recurrent   Pharyngotonsillitis Abdominal pain               GAS                                        ASO 690 IU/ml                         Atopic dermatitis                                           none
                                                                                                                      H.Pylori                                   Antigen in stools                                                                                 
                                                                                                                      EBV                                        IgM                                                                                               
  9\.           M              4.8                 Acute recurrent   none                                             none                                       none                                                                                              3
  10\.          M              2                   Acute recurrent   Pneumonia                                        Adenovirus                                 IgM                                   Atopic dermatitis                                           4
  11\.          F              2                   Acute             none                                             HHV-6                                      DNA saliva                            Rhinitis                                                    none
  12\.          F              11                  Acute             Pharyngotonsillitis                              CMV                                        IgM                                   Wheezing Prick: *Graminaceae*+                              none
  13\.          M              3.6                 Acute             Gastroenteritis                                  CMV                                        IgM                                   none                                                        3
  14\.          M              1.6                 Acute             Nasal herpes                                     EBV                                        IgM, DNA blood/saliva                 none                                                        5
                                                                                                                      HSV-1                                      IgM                                                                                               
  15\.          M              4.5                 Acute             Abdominal pain                                   none                                       none                                  Wheezing                                                    3
  16\.          F              2.5                 Acute recurrent   Otitis                                           HHV-6                                      DNA blood/saliva                      Wheezing                                                    4
  17\.          M              7                   Acute recurrent   Epididymitis                                     none                                       none                                  none                                                        none
  18\.          F              2.2                 Acute recurrent   none                                             HHV-6                                      DNA blood/saliva                      none                                                        4
                                                                                                                      ParvovirusB19                              IgM                                                                                               
  19\.          F              2                   Acute             Pharyngotonsillitis                              none                                       none                                  none                                                        none
  20\.          M              2.3                 Acute recurrent   none                                             none                                       none                                  none                                                        none
  21\.          F              0.5                 Acute recurrent   none                                             EBV                                        DNA saliva                            RAST: cow\'s milk 2.1 kU/L                                  none
  22\.          F              8.1                 Acute             Pharyngotonsillitis                              none                                       none                                  Rhinitis Prick: *Graminaceae*+                              none
  23\.          M              3                   Acute             none                                             none                                       none                                  none                                                        none
  24\.          F              2.4                 Acute recurrent   Pharyngotonsillitis                              CMV                                        DNA blood/saliva                      Atopic dermatitis                                           none
                                                                                                                      HHV-6                                      IgM                                                                                               
  25\.          F              0.4                 Acute recurrent   none                                             HHV-6                                      DNA saliva                            Atopic dermatitis                                           none
  26\.          M              0.7                 Acute recurrent   Pharyngotonsillitis Gastroenteritis              HHV-6                                      DNA blood/saliva                      none                                                        none
  27\.          F              1.0                 Acute             Wheezing                                         none                                       none                                  none                                                        none
  28\.          F              3                   Acute             Pharyngotonsillitis                              HHV-6                                      IgM                                   none                                                        none
  29\.          M              1.0                 Acute             Pharyngotonsillitis                              none                                       none                                  none                                                        none
  30\.          M              1.3                 Acute             none                                             none                                       none                                  none                                                        none
  31\.          M              8                   Acute             none                                             CMV                                        IgM                                   none                                                        none
  32\.          M              1.3                 Acute             Gingivostomatitis                                GAS                                        ASO 601 IU/ml                         RAST: *D. pteronissinus* 1.32 kU/L; *D. farinae* 0.8 kU/L   6
                                                                                                                      HSV-1                                      IgM                                                                                               
  33\.          F              1                   Acute             Urinary tract infection                          HHV-6                                      IgM                                   none                                                        none
  34\.          M              2                   Acute              none                                            CMV                                        IgM, DNA saliva                       RAST: egg 0.82 kU/L; cow\'s milk 0.76 kU/L                  none
  35\.          M              5.8                 Acute recurrent   Aphtous stomatitis                               GAS                                        ASO 552 IU/ml                         none                                                        none
                                                                                                                      HSV-1                                      IgM                                                                                               
  36\.          F              0.3                 Acute recurrent   none                                             CMV                                        IgM, DNA saliva                        RAST: cow\'s milk 1.63 kU/L                                
  37\.          F              8.1                 Acute recurrent   Pharyngotonsillitis                              GAS                                        Pharyngeal swab: GAS, ASO 477 IU/ml   none                                                        5
                                                                                                                      HHV-6                                      DNA saliva                                                                                        
                                                                                                                      CMV                                        IgM                                                                                               

GAS = Group A β-hemolytic Streptococcus

10.1371/journal.pone.0085378.t002

###### Characteristics of healthy controls.

  **Controls**     **Gender**     **Age (years)**     **Subclinical findings**   **Positive infectious tests**   **Allergic data**
  ---------------- -------------- ------------------- -------------------------- ------------------------------- ------------------------------------------------------
  1\.              M              1.9                 none                       none                            none
  2\.              F              1.1                 none                       none                            none
  3\.              M              3.8                 none                       none                            none
  4\.              M              7.1                 GAS                        ASO 502                         none
  5\.              F              7.8                 none                       none                            none
  6\.              M              10.1                GAS                        ASO 748                         none
  7\.              M              5.1                 none                       none                            none
  8\.              M              6                   GAS                        ASO 630                         none
  9\.              M              4.3                 none                       none                            none
  10               F              2.5                 GAS                        ASO 440                         none
                                                      HHV-6                      DNA saliva                      
  11\.             F              2.1                 CMV                        DNA saliva urine                none
  12\.             F              11                  none                       none                            none
  13\.             M              3.2                 none                       none                            none
  14\.             F              1.3                 none                       none                            none
  15               M              3.8                 none                       none                            RAST: cow\'s milk 2.9 kU/L
  16\.             F              2.8                 none                       none                            none
  17               F              7.6                 none                       none                            none
  18\.             F              2.3                 none                       none                            none
  19\.             F              2.1                 HHV-6                      DNA saliva                      none
  20\.             M              2.7                 Adenovirus                 IgM                             none
  21\.             M              0.7                 none                       none                            Atopic dermatitis
  22\.             M              9.5                 GAS                        ASO 361                         RAST: cow\'s milk 1.6 kU/L
                                                      CMV                        DNA saliva/urine                
  23\.             M              2.8                 GAS                        ASO 383                         none
  24               F              2.8                 none                       none                            none
  25\.             M              0.8                 none                       none                            none
  26\.             M              0.9                 none                       none                            none
  27\.             M              1.4                 none                       none                            none
  28               M              3.1                 none                       none                            Atopic dermatitis, Asthma
  29\.             M              1.3                 none                       none                            Atopic dermatitis Prick test: *D. pteronissinus*
  30\.             M              1.7                 none                       none                            none
  31\.             M              7.4                 GAS                        ASO 893                         none
  32\.             F              11.6                none                       none                            none
  33\.             M              1.9                 none                       none                            none
  34\.             M              0.1                 none                       none                            none
  35\.             F              5.7                 none                       none                            none
  36\.             F              0.6                 none                       none                            none
  37\.             M              10.4                none                       none                            Rhinoconjunctivitis RAST: *P. officinalis* 3.45 kU/L

10.1371/journal.pone.0085378.t003

###### Comparison of cases and controls for possible risk factors for urticaria.

  Characteristics                                                        Cases Disease N= 37   Controls No disease     N =37   Univariate P value   Multivariate     P value (adjusted odd ratio, 95% confidence interval)
  ---------------------------------------------------------------------- --------------------- ------------------------------- -------------------- ------------------------------------------------------------------------
  No of male cases                                                       20                    23                              0.63                 Not done
  Mean age [+]{.ul} SD of case and controls (years) -matching criteria   3.7[+]{.ul}3.0        3.9[+]{.ul}3.0                  Not done             Not done
  No. of children with CMV                                               8                     2                               0.12                 0.10 (3.5, 0.67-19)
  No. of children with HSV                                               4                     0                               0.13                 0.019[\*](#ngtab3.1){ref-type="table-fn"}
  No. of children with EBV                                               5                     0                               0.07                 0.017[\*](#ngtab3.1){ref-type="table-fn"}
  No. of children with HHV-6                                             10                    2                               0.043                0.019 (5.1, 1.06-24.3)
  No. of children with Adenovirus                                        1                     1                               0.48                 Not done
  No .of children with any herpes infection (CMV, HSV, EBV, HHV)         24                    4                               0.0003               Not done
  No. of children with Parvovirus                                        2                     0                               0.48                 Not done
  No. of children with *M. Pneumoniae*                                   2                     0                               0.48                 Not done
  No. of children with Rotavirus                                         1                     0                               1.00                 Not done
  Number of children with group A Streptococcal infections               5                     7                               0.75                 Not done
  No. of children with RAST/Prick                                        8                     4                               0.68                 Not done
  No. of children with allergy or atopy                                  5                     3                               1.00                 Not done
  No. of children with wheezing or rhinitis                              5                     1                               0.22                 Not done

^\*^ Too few subjects were infected to calculate an accurate odds ratio***.***

Laboratory and immunologic findings {#s3.2}
-----------------------------------

Fifteen cases had elevated leukocytes (\>9.1×10^3^/mm^3^) which ranged from 4.47×10^3^/mm^3^ to 34.7×10^3^/mm^3^ (mean values 10.27×10^3^/mm^3^) and of these 14 also had lymphocytosis. Ten cases had eosinophilia (\> 1500 eosinophils/mm^3^). Seven cases had increased platelets (\> 450×10^3^/mm^3^), 7 had an elevated ESR; 2 had an elevated CRP (\>0.5 mg/l); 3 had abnormal ALT and AST levels . Immunoglobulin, C3 and C4 levels were normal in all cases.

Risk factors {#s3.3}
------------

Ten cases (37%) had past allergic manifestations ([Table 1](#pone-0085378-t001){ref-type="table"}). Six cases had increased levels of specific IgE antibodies towards cow's milk, egg, *Dermatophagoides pteronissimus/farinae*. One case had an increased level of total IgE antibodies. Only two cases had positive skin prick tests to *Graminaceae*. Ibuprofen was the possible cause of acute urticaria in only one case.

Virologic findings {#s3.4}
------------------

Specific infections were diagnosed in 26 of 37 cases and among 9 of 37 control children (70% vs 24%; P=0.0002). Of infected cases, 25 had viral infections, six had viral-bacterial co-infections, six were infected with two viruses, and one had *M. pneumoniae* infection. Two or more infections occurred in 7 of 17 cases (41%) who had recurrent urticaria compared with two or more infections in 2 of 20 cases (10%) who had only one episode of urticaria (P =0.05).

The cases, compared to the age matched controls, had a higher prevalence of herpesvirus infections: single or concomitant herpesvirus infections occurred in 24 cases and in 4 controls (65% vs 11 %, p=0.0003, [Table 3](#pone-0085378-t003){ref-type="table"}). Cases had 27 herpesvirus infections, including 10 HHV-6 infections, 8 CMV infections, 5 EBV infections, and 4 HSV-1 infections ([Table 1](#pone-0085378-t001){ref-type="table"}). In 15 cases, 16 primary herpesvirus infections were identified by high levels of specific IgM and increasing IgG antibodies. One case was infected with two primary herpesvirus infections. In 9 cases, 11 active nonprimary herpesvirus infections were diagnosed by concomitant detection of specific DNA and high levels of IgG. Two cases had concomitant primary and nonprimary herpesvirus infections.

The only infections significantly associated with urticaria were infections with one of the four herpesviruses, CMV, EBV, HSV, or HHV-6 ([Table 3](#pone-0085378-t003){ref-type="table"}). In a multinomial regression analysis infections by HHV-6, HSV, and EBV were each independently predictive of acute or recurrent urticaria and CMV approached statistical significance (P = 0.1). None of the other infections whether viral or bacterial approached statistical significance ([Table 3](#pone-0085378-t003){ref-type="table"}). Among 24 cases with a herpesvirus infection, 13 (54%) had recurrent acute urticaria compared with recurrent acute urticaria in 4 of 13 (31%) cases without a herpesvirus infection (p = 0.3). Atopy or allergies were not statistically (p =0.3) more frequent among cases with herpesvirus infections (13/17 = 76%) than cases without (11/20 =55%).

Discussion {#s4}
==========

Acute urticaria occurs in 15% to 25% of people at a some point in their life, being associated with transudation of fluid from skin blood vessels and release of mediators from cutaneous mast cells and basophils \[[@B14]\] The release of mast cell-derived mediators may be caused by both immune and non immune mechanisms \[[@B15]\]. The association of acute urticaria with atopy is common, being found up to 50% of the cases and occasionally associated with an increase in total IgE level, which may represent a nonspecific marker of the immune mechanisms involved in urticaria rather than a sign of underlying atopy \[[@B12]\].

In children, acute urticaria is often considered as a food or drug allergy, leading to frequently unnecessary diet restrictions or elimination of drugs and administration of antihistaminic or corticosteroids. Identification of the true casual factors for urticaria would be very helpful in the management and prognosis. Possible causes, however, are numerous having been reported in between 21% to 83% of cases \[[@B2],[@B16]\]. This high variability is due to the various criteria used in evaluating the causes and the enrollment criteria. The various criteria used have included acute or chronic infections, non allergic hypersensitivity reactions to foods and drugs, and autoimmunity mediated by functional autoantibodies directed against the IgE receptors \[[@B13],[@B17]--[@B19]\]. Between 37% and 58%, of children with acute urticaria also have infections, usually virus-induced upper respiratory infections \[[@B2],[@B3]\]. Viral infections have also been associated to the onset of atopic manifestations and an increase in systemic IgE levels \[[@B20]\]. Infections, however, frequently also occur in patients with drug allergies making it difficult to distinguish between the two possible causal factors \[[@B16]\].

Ours is the first prospective age-matched case-control study to evaluate the association between acute or recurrent acute urticaria and a broad range of infectious causes in children. One previous study reported a 32% rate of *M. pneumoniae* infections among 65 children but a so called control group of 49 children with respiratory infections was not tested for *M. pneumoniae*. We found no evidence that acute urticaria was associated with Mycoplasma or streptococcal or respiratory viral infections. We did however observed that the onset of acute urticaria was strongly associated with an herpesvirus infection, including children who developed recurrent acute urticaria. Herpesviruses can persist long life alternating latent and reactivation phases, thus primary or reactivated herpesvirus infections may be associated with acute or recurrent acute urticaria. Cellular immunity controls herpesvirus infections and both primary and recurrent infections are associated with altered cell-mediated responsiveness and production of a number of cytokines \[[@B21]\]. As occurs in virus-induced asthma exacerbations after viral induction of mast cell activation, the activation of mast cells may be involved in herpesvirus-induced diseases, including the urticaria in genetically predisposed children \[[@B15],[@B22]\].

HHV-6, CMV and EBV infections are common in children. In particular the seroprevalence rate of HHV-6 is between 80% and 100% by the age of 3 years \[[@B23]\]. HHV-6 usually causes exanthema subitum but can affect the immunosurveillance system because of its tropism for T lymphocytes, monocytes/macrophages, and dendritic cells. In fact, HHV-6 stimulates the production of interferon-α and tumor necrosis factor-α, and upregulates NK cell cytotoxicity via interleukin-15 \[[@B24],[@B25]\]. CMV infection is common both pre and postnatally with an overall prevalence of between 15% and 25% among children, and also has many effects on the immune system mostly via cell-mediated immunity \[[@B21]\]. Eight children had persistent CMV DNA detection for more than 3 months after acute urticaria: six of these children developed recurrent acute urticaria. EBV and HSV-1 infections also stimulate cellular and antibody immune responses \[[@B21],[@B26]\]. Caubet et al. recently reported on a viral trigger, including acute EBV infections, for the urticaria or a red rash in 54/82 (66%) patients presenting to an emergency room with a negative oral challenge test (OCT). Interestingly, 3 of the patients with a positive OCT (50%) had findings suggestive of an acute or recent EBV infection \[[@B27]\].

Herpesviruses are a component of the human \"microbiome\" since they are adapted to lifelong infection of their hosts. Recent evidence suggest a possible role for herpesviruses in allergy and atopy \[[@B9]\]. Our results with urticaria and those with allergic and atopic reactions suggest physicians caring for allergic and atopic populations should be familiar with the manifestations of herpes-related disease \[[@B27],[@B28]\].

Because herpesvirus infections are common among children, possible limitations of our study include the small sample size and the practical limitation of only being able to obtain, in most cases, single specimens for diagnostic testing. Perhaps more subjects and repetitive testing would skew the results. Nevertheless with a significantly higher rate than controls, we observed a herpesvirus infection in 65% of our patients which suggests herpesviruses may be component of the process involved in development of acute or recurrent acute urticaria.
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